Maximus, Inc. (NYSE:MMS) President Bruce Caswell sold 8,000 shares of the firm’s stock in a transaction on Thursday, May 18th. The stock was sold at an average price of $61.79, for a total value of $494,320.00. Following the completion of the sale, the president now directly owns 35,904 shares of the company’s stock, valued at $2,218,508.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Bruce Caswell also recently made the following trade(s):

  • On Monday, June 5th, Bruce Caswell sold 8,000 shares of Maximus stock. The shares were sold at an average price of $63.48, for a total value of $507,840.00.
  • On Tuesday, May 23rd, Bruce Caswell sold 8,000 shares of Maximus stock. The shares were sold at an average price of $62.76, for a total value of $502,080.00.
  • On Thursday, May 11th, Bruce Caswell sold 17,197 shares of Maximus stock. The shares were sold at an average price of $62.47, for a total value of $1,074,296.59.

Maximus, Inc. (MMS) traded down 0.96% during midday trading on Friday, reaching $63.76. The company had a trading volume of 663,736 shares. The company has a market capitalization of $4.13 billion, a price-to-earnings ratio of 20.90 and a beta of 1.45. The firm has a 50-day moving average price of $62.76 and a 200-day moving average price of $59.31. Maximus, Inc. has a 52 week low of $43.69 and a 52 week high of $64.97.

Maximus (NYSE:MMS) last issued its quarterly earnings results on Thursday, May 4th. The health services provider reported $0.80 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.78 by $0.02. Maximus had a return on equity of 26.21% and a net margin of 8.18%. The business had revenue of $622 million during the quarter, compared to analyst estimates of $620.24 million. During the same quarter in the prior year, the business posted $0.74 EPS. Maximus’s revenue for the quarter was up 2.6% compared to the same quarter last year. Analysts expect that Maximus, Inc. will post $3.05 EPS for the current fiscal year.

Insider Buying and Selling by Quarter for Maximus (NYSE:MMS)

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 31st. Shareholders of record on Monday, May 15th were paid a $0.045 dividend. The ex-dividend date of this dividend was Thursday, May 11th. This represents a $0.18 dividend on an annualized basis and a yield of 0.28%. Maximus’s payout ratio is presently 5.86%.

COPYRIGHT VIOLATION NOTICE: “Insider Selling: Maximus, Inc. (MMS) President Sells 8,000 Shares of Stock” was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international copyright laws. The correct version of this piece can be accessed at https://www.thecerbatgem.com/2017/06/16/insider-selling-maximus-inc-mms-president-sells-494320-00-in-stock-updated-updated.html.

A number of large investors have recently modified their holdings of the company. Russell Investments Group Ltd. acquired a new stake in shares of Maximus during the fourth quarter worth about $19,752,000. First Bank & Trust acquired a new stake in shares of Maximus during the fourth quarter worth about $135,000. D.A. Davidson & CO. raised its stake in shares of Maximus by 4.6% in the third quarter. D.A. Davidson & CO. now owns 79,470 shares of the health services provider’s stock worth $4,491,000 after buying an additional 3,463 shares during the last quarter. Sawtooth Solutions LLC raised its stake in shares of Maximus by 14.0% in the third quarter. Sawtooth Solutions LLC now owns 6,246 shares of the health services provider’s stock worth $353,000 after buying an additional 766 shares during the last quarter. Finally, Intl Fcstone Inc. acquired a new stake in shares of Maximus during the third quarter worth about $203,000. Institutional investors and hedge funds own 98.67% of the company’s stock.

Several brokerages have recently weighed in on MMS. Jefferies Group LLC cut Maximus from a “buy” rating to a “hold” rating and lifted their price target for the company from $63.00 to $64.00 in a research report on Friday, May 5th. Maxim Group cut Maximus from a “buy” rating to a “hold” rating and set a $66.00 price target for the company. in a research report on Thursday, May 4th. They noted that the move was a valuation call. ValuEngine cut Maximus from a “buy” rating to a “hold” rating in a research report on Tuesday, May 16th. KeyCorp reiterated a “sector weight” rating on shares of Maximus in a research report on Thursday, May 25th. Finally, Canaccord Genuity reiterated a “buy” rating and issued a $62.00 price target on shares of Maximus in a research report on Friday, April 7th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and one has given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $61.33.

Maximus Company Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Receive News & Stock Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related stocks with our FREE daily email newsletter.